Researchers at Ben-Gurion University of the Negev have identified a protein that plays a central role in enabling aggressive breast cancer cells to spread to other parts of the body. Triple-negative breast cancer remains one of the most challenging diagnoses to receive. While medical advances have improved the ability to surgically remove primary tumors, the true danger lies in metastasis, which is the spread of cancer cells to vital organs like the lungs, liver, or brain. Researchers at Ben-Gurion University of the Negev have now identified a specific protein, PKC-eta (protein kinase C-eta), that drives this deadly cell migration in triple-negative breast cancer, offering a new avenue of hope for treating this aggressive disease.
Continue Reading this article here
